Edition:
United States

DelMar Pharmaceuticals Inc (DMPI.OQ)

DMPI.OQ on NASDAQ Stock Exchange Capital Market

0.96USD
22 May 2018
Change (% chg)

$-0.02 (-2.42%)
Prev Close
$0.98
Open
$0.98
Day's High
$0.98
Day's Low
$0.96
Volume
4,020
Avg. Vol
49,697
52-wk High
$2.83
52-wk Low
$0.78

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec 0.00 -0.143
Sep 0.00 -0.177
FY 2017 Jun '17 0.00 -0.195
Mar '17 0.00 -0.180
Dec 0.00 -0.130
Sep 0.00 -0.230
FY 2016 Jun '16 0.00 -0.333
Mar '16 0.00 -0.103
Dec 0.00 -0.241
Sep 0.00 -0.153
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Jun-18 1 0.00 0.00 0.00 0.00
Year Ending Jun-19 1 5.00 5.00 5.00 0.00
Earnings (per share)
Quarter Ending Dec-18 1 -0.06 -0.06 -0.06 --
Quarter Ending Mar-18 1 -0.10 -0.10 -0.10 --
Year Ending Jun-18 2 -0.50 -0.46 -0.55 -0.41
Year Ending Jun-19 2 -0.25 -0.25 -0.26 -0.50
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 28.49 19.46
P/E High - Last 5 Yrs. -- 19.94 25.63
P/E Low - Last 5 Yrs. -- 4.83 11.88
Beta 1.50 1.08 1.40
Price to Sales (TTM) -- 15.51 349.06
Price to Book (MRQ) 6.24 3.70 2.69
Price to Tangible Book (MRQ) 2.18 7.90 2.87
Price to Cash Flow (TTM) -- 5.00 29.82
% Owned Institutions 15.70 0.70 0.87

Dividends

  Company industry sector
Dividend Yield -- 2.87 2.53
Dividend Yield - 5 Year Avg -- 3.05 2.10
Dividend 5 Year Growth Rate -- 6.56 23.76
Payout Ratio(TTM) -- 38.22 104.33

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -7.93 13.56
Sales (TTM) vs TTM 1 Yr. Ago -- -2.37 9.27
Sales - 5 Yr. Growth Rate -- 26.02 13.97
EPS (MRQ) vs Qtr. 1 Yr. Ago -9.90 -45.86 37.54
EPS (TTM) vs TTM 1 Yr. Ago 12.66 -- --
EPS - 5 Yr. Growth Rate -- 5.03 10.53
Capital Spending - 5 Yr. Growth Rate -- 57.14 1.44

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.06 0.06
Current Ratio (MRQ) 5.47 25.09 1.89
LT Debt to Equity (MRQ) 0.00 30.37 33.27
Total Debt to Equity (MRQ) 0.00 34.55 65.76
Interest Coverage (TTM) -7.12 268.58 6.98

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.70 3.58
Gross Margin - 5 Yr. Avg. -- 45.02 3.43
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 32.61 45.79
Operating Margin (TTM) -- 74.60 36.04
Operating Margin - 5 Yr. Avg. -- 117.97 39.35
Pre-Tax Margin (TTM) -- 72.65 38.86
Pre-Tax Margin - 5 Yr. Avg. -- 116.67 39.82
Net Profit Margin (TTM) -- 71.85 31.28
Net Profit Margin - 5 Yr. Avg. -- 115.78 31.58
Effective Tax Rate (TTM) -- 4.63 20.76
Effective Tax Rate - 5 Yr. Avg. -- 3.87 20.81

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 39,264,594 51,586,734
Net Income/Employee (TTM) -2,574,365 62,148,334 24,169,912
Receivable Turnover (TTM) -- 9.04 10,624.19
Inventory Turnover (TTM) -- 5.01 0.96
Asset Turnover (TTM) 0.00 0.17 0.02

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -130.26 1.51 2.80
Return on Assets - 5 Yr. Avg. -- -14.52 2.77
Return on Investment (TTM) -160.12 4.74 0.59
Return on Investment - 5 Yr. Avg. -- 9.88 0.53
Return on Equity (TTM) -- 6.21 16.31
Return on Equity - 5 Yr. Avg. -- 11.94 18.32
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 11.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for DelMar Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 15.70%
# of Holders: 16
Total Shares Held: 3,456,985
3 Mo. Net Change: 138,065
# New Positions: 5
# Closed Positions: 1
# Increased Positions: 10
# Reduced Positions: 1
# Net Buyers: 9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.